SCHEMBL7985320

SCHEMBL7985320

CN(Cc1nc2ncn(CCCc3ccccc3)c2c(=O)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
ALDH1A1 P00352 3/20 0.42
CNOT7 Q9UIV1 1/20 0.42
HPGD P15428 1/20 0.41
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
CACNA1G O43497 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNA1C Q13936 1/20 0.37
MCL1 Q07820 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
GLS O94925 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991611 0.95 HPGD (0.42) LMNAKDM4EPOLBMAPK1ALDH1A1
SCHEMBL7985463 0.89 HPGD (0.52) MAPK1ALDH1A1CNOT7HPGDSMN1; SMN2
SCHEMBL7985316 0.86 CNOT7 (0.48) LMNAKDM4EPOLBMAPK1ALDH1A1
SCHEMBL7985311 0.83 HTR2C (0.40) LMNAKDM4EPOLBMAPK1ALDH1A1
SCHEMBL7974033 0.82 HPGD (0.49) ALDH1A1CNOT7HPGDSMN1; SMN2HTR2C
SCHEMBL7988916 0.82 HPGD (0.50) ALDH1A1CNOT7HPGDSMN1; SMN2HTR2C
SCHEMBL7975231 0.81 CACNA1G (0.40) LMNAPOLBALDH1A1HPGDSMN1; SMN2
SCHEMBL7987946 0.81 HPGD (0.42) LMNAALDH1A1HPGDSMN1; SMN2HTR2C
SCHEMBL7974183 0.81 HPGD (0.51) LMNAALDH1A1CNOT7HPGDSMN1; SMN2
SCHEMBL7988125 0.81 HPGD (0.43) MAPK1ALDH1A1HPGDSMN1; SMN2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed